In obesity, it has been reported that there are significant changes in the gut-immune cell composition, leading to metabolic inflammation and gut dysbiosis via upregulation of inflammatory mediators like TLR4, TNF, and NFkB (112, 113). The gene discussed is NFKB1; the disease is obesity disorder.